ORPHAGEN PHARMACEUTICALS, INC. SBIR Phase I Award, July 2015
A SBIR Phase I contract was awarded to Orphagen Pharmaceuticals in July, 2015 for $224,954.0 USD from the U.S. Department of Health & Human Services.
Is a
Award Amount (USD)
224,954
0
Date Awarded
July 1, 2015
0
End Date
June 30, 2016
0
SBIR/STTR Award Recipient
Contract Number (US Government)
1R43CA200076-01
0
Award Phase
Phase I
0
Award Type
SBIR
0
Official Website
Find more entities like ORPHAGEN PHARMACEUTICALS, INC. SBIR Phase I Award, July 2015
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.